A 30-Year Quest For Alzheimer's Remedy Nears The Finish LineBloomberg News
TauRx will soon unveil human trial results for its drug LMTX
Singapore company's backers include Genting Berhad and Temasek
After decades of researching a treatment for Alzheimer’s, Claude Wischik is set to find out whether his lonely 30-year battle can lead to one of the first real treatments for the memory-destroying brain disorder that afflicts millions worldwide.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.